INCY Incyte
Permanent stock page ↗Health Care · S&P 500
Next earnings: not announced yet
What 31 analyst firms say about Incyte: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
27 rated views · 31 analyst/firm records · 31 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8034
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8037
Recent analyst activity · last 90 days
Our tracked history has 42 reports on INCY from 25 analyst firms in the last 90 days (31 firms in the past year).
Comparing each firm's latest target with its previous one: 11 raised their price target, 1 lowered it, 4 left it unchanged and 4 have their first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Bernstein raised its target from $104.00 (set 13 Aug 2026) to $108.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Jasper Hellweg | Buy | 31 Jul 2026 | 140.00 USD |
| Barclays | Etzer Darout | Buy | 30 Oct 2026 | 143.00 USD |
| Benchmark | Unnamed analyst | Buy | 13 Oct 2026 | — |
| Bernstein | Jeffrey Walch | Hold | 26 Sep 2026 | Conflicting reports · excluded |
| BMO Capital Markets | Evan David Seigerman | Hold | 27 Oct 2026 | 130.00 USD · 13 Oct 2026 |
| Canaccord Genuity | John Newman | Buy | 20 Aug 2026 | 152.00 USD |
| Cantor Fitzgerald | Eric Schmidt | Hold | 11 Sep 2026 | — |
| Citigroup | Unnamed analyst | Buy | 3 Aug 2026 | — |
| Citizens JMP | Reni Benjamin | Hold | 2 Apr 2026 | — |
| Evercore ISI | Gavin Clark-Gartner | Hold | 30 Oct 2026 | 127.00 USD |
| Goldman Sachs | Salveen Richter | Hold | 22 Oct 2026 | Conflicting reports · excluded |
| Guggenheim | Michael Schmidt | Buy | 29 Oct 2026 | 152.00 USD |
| H.C. Wainwright | Mitchell S. Kapoor | Buy | 27 Oct 2026 | 152.00 USD · 13 Oct 2026 |
| Jefferies | Faisal Khurshid | Hold | 17 Jun 2026 | 115.00 USD |
| JPMorgan | Jessica Fye | Hold | 28 Sep 2026 | 123.00 USD |
| Leerink Partners | Andrew Berens | Buy | 3 Aug 2026 | Conflicting reports · excluded |
| Mizuho | Salim Syed | Buy | 4 Aug 2026 | 137.00 USD |
| Morgan Stanley | Judah Frommer | Hold | 20 Oct 2026 | 119.00 USD |
| Oppenheimer | Jay Olson | — | 27 Oct 2026 | 152.00 USD |
| Piper Sandler | Allison M Bratzel | Buy | 20 Oct 2026 | 130.00 USD |
| Raymond James | Unnamed analyst | — | 16 Oct 2026 | 152.00 USD |
| RBC Capital Markets | Brian Abrahams | Hold | 30 Oct 2026 | 117.00 USD |
| Stifel | Stephen Willey | Buy | 5 Oct 2026 | 157.00 USD |
| TD Cowen | Tara Bancroft | Buy | 21 Oct 2026 | 140.00 USD |
| Truist | Srikripa Devarakonda | Hold | 14 Oct 2026 | 115.00 USD |
| UBS | Ashwani Verma | — | 30 Oct 2026 | 152.00 USD |
| Weiss Ratings | Unnamed analyst | — | 23 Oct 2026 | — |
| Wells Fargo | Derek Archila | Hold | 30 Oct 2026 | 127.00 USD |
| William Blair | Matt Phipps | Hold | 27 Oct 2026 | — |
| Wolfe Research | Andy G Chen | Buy | 3 Aug 2026 | 135.00 USD |
| Data feed RESEARCH | Research Team | Sell | 14 Oct 2026 | 95.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:25 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.